(Q35173859)

6 August 2017

1 reference

title

Peroxisome proliferator-activated receptors and the cardiovascular system (English)

1 reference

6 August 2017

Yuqing E Chen

1

1 reference

6 August 2017

Mingui Fu

2

1 reference

6 August 2017

Jifeng Zhang

3

1 reference

6 August 2017

Xiaojun Zhu

4

1 reference

6 August 2017

Yiming Lin

5

1 reference

6 August 2017

Mukaila A Akinbami

6

1 reference

6 August 2017

Qing Song

7

1 reference

6 August 2017

language of work or name

1 reference

1 January 2003

1 reference

6 August 2017

published in

Vitamins and Hormones

1 reference

6 August 2017

volume

66

1 reference

6 August 2017

page(s)

157-188

1 reference

Transcriptional activation by peroxisome proliferator-activated receptor gamma is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

cDNA cloning and characterization of the transcriptional activities of the hamster peroxisome proliferator-activated receptor haPPAR gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Peroxisome proliferator-activated receptor gamma plays a critical role in inhibition of cardiac hypertrophy in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

PPAR gamma is required for placental, cardiac, and adipose tissue development

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Effects of peroxisome proliferator-activated receptor delta on placentation, adiposity, and colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Pleiotropic actions of peroxisome proliferator-activated receptors in lipid metabolism and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Association of the Pro12Ala variant in the peroxisome proliferator-activated receptor-gamma2 gene with obesity in two Caucasian populations

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Molecular basis of non-responsiveness to peroxisome proliferators: the guinea-pig PPARalpha is functional and mediates peroxisome proliferator-induced hypolipidaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

The mechanisms of action of PPARs

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Egr-1 activates basic fibroblast growth factor transcription. Mechanistic implications for astrocyte proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Intimal smooth muscle cells as a target for peroxisome proliferator-activated receptor-gamma ligand therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Peroxisome proliferator-activated receptor alpha (PPARalpha ) turnover by the ubiquitin-proteasome system controls the ligand-induced expression level of its target genes

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Influences of the PPAR alpha-L162V polymorphism on plasma HDL(2)-cholesterol response of abdominally obese men treated with gemfibrozil

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Identification of peroxisome proliferator-activated receptor ligands from a biased chemical library.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

A ureido-thioisobutyric acid (GW9578) is a subtype-selective PPARalpha agonist with potent lipid-lowering activity

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

A role for peroxisome proliferator-activated receptor alpha (PPARalpha ) in the control of cardiac malonyl-CoA levels: reduced fatty acid oxidation rates and increased glucose oxidation rates in the hearts of mice lacking PPARalpha are associated wi

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Dual function of troglitazone in ICAM-1 gene expression in human vascular endothelium

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Troglitazone inhibits atherosclerosis in apolipoprotein E-knockout mice: pleiotropic effects on CD36 expression and HDL.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Troglitazone inhibits formation of early atherosclerotic lesions in diabetic and nondiabetic low density lipoprotein receptor-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Transcriptional effects of chronic Akt activation in the heart.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Peroxisome Proliferator-activated Receptor α Negatively Regulates the Vascular Inflammatory Gene Response by Negative Cross-talk with Transcription Factors NF-κB and AP-1

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Peroxisome proliferator-activated receptor activators inhibit thrombin-induced endothelin-1 production in human vascular endothelial cells by inhibiting the activator protein-1 signaling pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Induction of IκBα Expression as a Mechanism Contributing to the Anti-inflammatory Activities of Peroxisome Proliferator-activated Receptor-α Activators

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Peroxisome proliferator-activated receptors: nuclear control of metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

The PPARalpha-leukotriene B4 pathway to inflammation control.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Chemical probes that differentially modulate peroxisome proliferator-activated receptor alpha and BLTR, nuclear and cell surface receptors for leukotriene B(4).

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Structure, endothelial function, cell growth, and inflammation in blood vessels of angiotensin II-infused rats: role of peroxisome proliferator-activated receptor-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Expression of porcine adipocyte transcripts: tissue distribution and differentiation in vitro and in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Rat PPARs: Quantitative Analysis in Adult Rat Tissues and Regulation in Fasting and Refeeding

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

A polymorphism, L162V, in the peroxisome proliferator-activated receptor alpha (PPARalpha) gene is associated with lower body mass index in patients with non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

The organization, promoter analysis, and expression of the human PPARgamma gene

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

PPARgamma3 mRNA: a distinct PPARgamma mRNA subtype transcribed from an independent promoter

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Peroxisome proliferator-activated receptor alpha gene variants influence progression of coronary atherosclerosis and risk of coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Peroxisome proliferator-activated receptor gamma inhibits transforming growth factor beta-induced connective tissue growth factor expression in human aortic smooth muscle cells by interfering with Smad3

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Platelet-derived growth factor promotes the expression of peroxisome proliferator-activated receptor gamma in vascular smooth muscle cells by a phosphatidylinositol 3-kinase/Akt signaling pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Early growth response factor-1 is a critical transcriptional mediator of peroxisome proliferator-activated receptor-gamma 1 gene expression in human aortic smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Activation of peroxisome proliferator-activated receptor gamma inhibits osteoprotegerin gene expression in human aortic smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Thiazolidinediones, peroxisome proliferator-activated receptor gamma agonists, regulate endothelial cell growth and secretion of vasoactive peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Transcription coactivator TRAP220 is required for PPAR gamma 2-stimulated adipogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

p300 interacts with the N- and C-terminal part of PPARgamma2 in a ligand-independent and -dependent manner, respectively

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Negative regulation of human fibrinogen gene expression by peroxisome proliferator-activated receptor alpha agonists via inhibition of CCAAT box/enhancer-binding protein beta

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Peroxisome proliferator-activated receptor-gamma ligands inhibit nuclear but not cytosolic extracellular signal-regulated kinase/mitogen-activated protein kinase-regulated steps in vascular smooth muscle cell migration

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Rat peroxisome proliferator-activated receptors and brown adipose tissue function during cold acclimatization

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Prostacyclin-mediated activation of peroxisome proliferator-activated receptor delta in colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Peroxisome proliferator-activated receptor alpha (PPAR alpha) agonist, WY-14,643, increased transcription of myosin light chain-2 in cardiomyocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Oxidized LDL reduces monocyte CCR2 expression through pathways involving peroxisome proliferator-activated receptor gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Peroxisome proliferator-activated receptor delta (PPARdelta )-mediated regulation of preadipocyte proliferation and gene expression is dependent on cAMP signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Peroxisome proliferator-activated receptor delta activation promotes cell survival following hypertonic stress

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Effect of the peroxisome proliferator-activated receptor-gamma 2 pro(12)ala variant on obesity, glucose homeostasis, and blood pressure in members of familial type 2 diabetic kindreds

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Troglitazone upregulates nitric oxide synthesis in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Degradation of the peroxisome proliferator-activated receptor gamma is linked to ligand-dependent activation

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Peroxisome proliferator-activated receptor a ligands increase lectin-like oxidized low density lipoprotein receptor-1 expression in vascular endothelial cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Relationships of PPARγ and PPARγ2 mRNA levels to obesity, diabetes and hyperinsulinaemia in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Oxidized low-density lipoprotein and peroxisome-proliferator-activated receptor alpha down-regulate platelet-activating-factor receptor expression in human macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

TZDs inhibit vascular smooth muscle cell growth independently of the cyclin kinase inhibitors p21 and p27.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Peroxisome proliferator-activated receptor-gamma ligands inhibit nitric oxide synthesis in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Suppression of rat thromboxane synthase gene transcription by peroxisome proliferator-activated receptor gamma in macrophages via an interaction with NRF2.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Expression of peroxisome proliferator-activated receptor alpha (PPAR alpha) in primary cultures of human vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Lipophilic HMG-CoA reductase inhibitor has an anti-inflammatory effect: reduction of MRNA levels for interleukin-1beta, interleukin-6, cyclooxygenase-2, and p22phox by regulation of peroxisome proliferator-activated receptor alpha (PPARalpha) in pri

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

The ligands/activators for peroxisome proliferator-activated receptor alpha (PPARalpha) and PPARgamma increase Cu2+,Zn2+-superoxide dismutase and decrease p22phox message expressions in primary endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Oxidized LDL regulates vascular endothelial growth factor expression in human macrophages and endothelial cells through activation of peroxisome proliferator-activated receptor-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Peroxisome proliferator-activated receptor activators target human endothelial cells to inhibit leukocyte-endothelial cell interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Peroxisome proliferator--activated receptor alpha gene regulates left ventricular growth in response to exercise and hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Peroxisome-proliferator-activated receptor delta mediates the effects of long-chain fatty acids on post-confluent cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Regulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Regulation of the transcriptional activity of the peroxisome proliferator-activated receptor alpha by phosphorylation of a ligand-independent trans-activating domain

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Thiazolidinediones down-regulate plasminogen activator inhibitor type 1 expression in human vascular endothelial cells: A possible role for PPARgamma in endothelial function.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Mechanisms of vasorelaxation induced by troglitazone, a novel antidiabetic drug, in the porcine coronary artery

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Roles of PPARs in health and disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Egr-1-induced endothelial gene expression: a common theme in vascular injury

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Egr-1 is activated in endothelial cells exposed to fluid shear stress and interacts with a novel shear-stress-response element in the PDGF A-chain promoter

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Rosiglitazone, a peroxisome proliferator-activated receptor-gamma, inhibits the Jun NH(2)-terminal kinase/activating protein 1 pathway and protects the heart from ischemia/reperfusion injury

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Differential expression and activation of a family of murine peroxisome proliferator-activated receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

PPARgamma but not PPARalpha ligands are potent repressors of major histocompatibility complex class II induction in atheroma-associated cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Expression and function of PPARgamma in rat and human vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Progress in cardiovascular biology: PPAR for the course

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Role for peroxisome proliferator-activated receptor alpha in oxidized phospholipid-induced synthesis of monocyte chemotactic protein-1 and interleukin-8 by endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Activation of PPARdelta alters lipid metabolism in db/db mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

PPAR Tissue Distribution and Interactions with Other Hormone-Signaling Pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Current concepts in cardiovascular pathology: the role of LDL cholesterol in plaque rupture and stabilization

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Cyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPARdelta

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Comparison of complete nuclear receptor sets from the human, Caenorhabditis elegans and Drosophila genomes

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Pro12Ala substitution in the peroxisome proliferator-activated receptor-gamma2 is not associated with type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Cloning and function of rabbit peroxisome proliferator-activated receptor delta/beta in mature osteoclasts

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Macrophages in human atheroma contain PPARgamma: differentiation-dependent peroxisomal proliferator-activated receptor gamma(PPARgamma) expression and reduction of MMP-9 activity through PPARgamma activation in mononuclear phagocytes in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

PPARgamma activation in human endothelial cells increases plasminogen activator inhibitor type-1 expression: PPARgamma as a potential mediator in vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

PPARalpha activators inhibit cytokine-induced vascular cell adhesion molecule-1 expression in human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Peroxisome proliferator-activated receptor-gamma activators inhibit IFN-gamma-induced expression of the T cell-active CXC chemokines IP-10, Mig, and I-TAC in human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

PPARalpha activators inhibit tissue factor expression and activity in human monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

PPAR activators as antiinflammatory mediators in human T lymphocytes: implications for atherosclerosis and transplantation-associated arteriosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Expression of macrophage (Mphi) scavenger receptor, CD36, in cultured human aortic smooth muscle cells in association with expression of peroxisome proliferator activated receptor-gamma, which regulates gain of Mphi-like phenotype in vitro, and its

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Genetic locus in mice that blocks development of atherosclerosis despite extreme hyperlipidemia

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

A genetic polymorphism of the peroxisome proliferator-activated receptor gamma gene influences plasma leptin levels in obese humans

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Improved insulin-sensitivity in mice heterozygous for PPAR-gamma deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

15-Deoxy-Delta(12,14)-prostaglandin J(2) induces G(1) arrest and differentiation marker expression in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

The role of PPAR-gamma in macrophage differentiation and cholesterol uptake.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Repression of TNF-alpha-induced E-selectin expression by PPAR activators: involvement of transcriptional repressor LRF-1/ATF3

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

PPARalpha agonists inhibit tissue factor expression in human monocytes and macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Stimulation of peroxisome-proliferator-activated receptor alpha (PPAR alpha) attenuates cardiac fibrosis and endothelin-1 production in pressure-overloaded rat hearts

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Enhancement of insulin sensitivity by troglitazone lowers blood pressure in diabetic hypertensives.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

PPARgamma ligand inhibits osteopontin gene expression through interference with binding of nuclear factors to A/T-rich sequence in THP-1 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Genetic disruption of PPARdelta decreases the tumorigenicity of human colon cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Tumor suppressor and anti-inflammatory actions of PPARgamma agonists are mediated via upregulation of PTEN.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-gamma activators

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor beta(delta)

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Obesity associated with a mutation in a genetic regulator of adipocyte differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

PPARalpha and PPARdelta activators inhibit cytokine-induced nuclear translocation of NF-kappaB and expression of VCAM-1 in EAhy926 endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

PPARγ Is Required for the Differentiation of Adipose Tissue In Vivo and In Vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Coregulator codes of transcriptional regulation by nuclear receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Atherosclerosis — An Inflammatory Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Peroxisome proliferator activated receptors in Atlantic salmon (Salmo salar): effects on PPAR transcription and acyl-CoA oxidase activity in hepatocytes by peroxisome proliferators and fatty acids

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Fatty acid oxidation enzyme gene expression is downregulated in the failing heart

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Thiazolidinediones suppress endothelin-1 secretion from bovine vascular endothelial cells: a new possible role of PPARgamma on vascular endothelial function.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Identification of a new member of the steroid hormone receptor superfamily that is activated by a peroxisome proliferator and fatty acids

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

cDNA cloning, chromosomal mapping, and functional characterization of the human peroxisome proliferator activated receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

The peroxisome proliferator-activated receptor delta, an integrator of transcriptional repression and nuclear receptor signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Pathways of Egr-1-mediated gene transcription in vascular biology

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

A regulatory element in the human interleukin 2 gene promoter is a binding site for the zinc finger proteins Sp1 and EGR-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

The hormone resistin links obesity to diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

15-deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

The peroxisome proliferator-activated receptor-gamma2 Pro12Ala polymorphism

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Transcriptional suppression of type 1 angiotensin II receptor gene expression by peroxisome proliferator-activated receptor-gamma in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Transcription suppression of thromboxane receptor gene by peroxisome proliferator-activated receptor-gamma via an interaction with Sp1 in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Vasodilatory effects of troglitazone improve blood pressure at rest and during mental stress in type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Insulin-induced vasodilatation and endothelial function in obesity/insulin resistance. Effects of troglitazone.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Alteration of a Single Amino Acid in Peroxisome Proliferator-Activated Receptor- (PPAR ) Generates a PPAR Phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Peroxisome proliferator-activated receptor activators inhibit lipopolysaccharide-induced tumor necrosis factor-alpha expression in neonatal rat cardiac myocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Peroxisome proliferator-activated receptor-gamma activation inhibits interleukin-1beta -mediated platelet-derived growth factor-alpha receptor gene expression via CCAAT/enhancer-binding protein-delta in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Peroxisome proliferator-activated receptor gamma activators downregulate angiotensin II type 1 receptor in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Two Polymorphisms in the Peroxisome Proliferator-Activated Receptor- Gene Are Associated with Severe Overweight among Obese Women

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

The peroxisome proliferator-activated receptor delta promotes lipid accumulation in human macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Peroxisome proliferator-activated receptor gamma ligands inhibit retinoblastoma phosphorylation and G1--> S transition in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Peroxisome proliferator-activated receptor gamma ligands inhibit mitogenic induction of p21(Cip1) by modulating the protein kinase Cdelta pathway in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Peroxisome proliferator-activated receptor gamma C161-->T polymorphism and coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Ligands of the peroxisome proliferator-activated receptors (PPAR-gamma and PPAR-alpha) reduce myocardial infarct size

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

The PPARs: from orphan receptors to drug discovery

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Peroxisome proliferator-activated receptor gamma ligands are potent inhibitors of angiogenesis in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Rat PPAR delta contains a CGG triplet repeat and is prominently expressed in the thalamic nuclei

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Peroxisome proliferator-activated receptor-gamma agonists increase vascular endothelial growth factor expression in human vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Lipopolysaccharide induction of the tumor necrosis factor-alpha promoter in human monocytic cells. Regulation by Egr-1, c-Jun, and NF-kappaB transcription factors

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Molecular scanning of the human peroxisome proliferator activated receptor gamma (hPPAR gamma) gene in diabetic Caucasians: identification of a Pro12Ala PPAR gamma 2 missense mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

In vivo myocardial protection from ischemia/reperfusion injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Peroxisome proliferator-activated receptor delta is up-regulated during vascular lesion formation and promotes post-confluent cell proliferation in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Genetic analysis of four novel peroxisome proliferator activated receptor-gamma splice variants in monkey macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Cross-talk between janus kinase-signal transducer and activator of transcription (JAK-STAT) and peroxisome proliferator-activated receptor-alpha (PPARalpha) signaling pathways. Growth hormone inhibition of pparalpha transcriptional activity mediated

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Isolation and characterization of PBP, a protein that interacts with peroxisome proliferator-activated receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Peroxisome proliferator-activated receptor (PPAR)-gamma expression in human vascular smooth muscle cells: inhibition of growth, migration, and c-fos expression by the peroxisome proliferator-activated receptor (PPAR)-gamma activator troglitazone

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

Differential involvement of peroxisome-proliferator-activated receptors alpha and delta in fibrate and fatty-acid-mediated inductions of the gene encoding liver fatty-acid-binding protein in the liver and the small intestine

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2803%2901005-7

7 January 2021

10.1016/S0083-6729(03)01005-7

Identifiers

DOI

1 reference

6 August 2017

1 reference